DTL
TECX

Dynamic Technology Lab’s Tectonic Therapeutic TECX Stock Holding History

Dynamic Technology Lab’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-951
Closed -$63K – 1555
2021
Q3 		$63K Buy
+951
New +$78K 0.01% 996

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Dynamic Technology Lab's TECX Position: Q4 2021 in Review

Dynamic Technology Lab sold out of Tectonic Therapeutic (TECX) in Q4 2021, closing a stake of 951 shares — an estimated $63K sold.

Dynamic Technology Lab first reported a position in TECX in Q3 2021 and held it in 1 quarter. The position peaked at $63K in Q3 2021. 92 funds tracked by Wall St. Rank hold TECX as of Q4 2021.

  • Dynamic Technology Lab reported no remaining Tectonic Therapeutic position as of Q4 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 951 Tectonic Therapeutic shares in Q4 2021, an estimated $63K.
  • Dynamic Technology Lab first reported a position in Tectonic Therapeutic in Q3 2021 and held it in 1 quarter.
  • Dynamic Technology Lab's Tectonic Therapeutic position peaked at $63K in Q3 2021.
  • 92 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2021.

Based on Dynamic Technology Lab's 13F filing for Q4 2021, filed 14 Feb 2022.